2021 SDi Cell & Gene Therapy Technologies and Supplies
19 Apr 2021
21-051 Cell & Gene Therapy Technologies and Supplies
Cell and gene therapy (CGT) is a rapidly evolving field producing powerful new treatments for cancers and genetic diseases, and expanding into autoimmune disease, cardiovascular disease, musculoskeletal disease, and many others.
This 2021 SDi report provides background and market data on 21 key technologies and supplies used by CGT providers, from the R&D phase through manufacturing and cryopreservation. The report offers market size, growth, segmentations, and vendor share.
Cell and gene therapy (CGT) is a rapidly evolving field producing powerful new treatments for cancers and genetic diseases, and expanding into autoimmune disease, cardiovascular disease, musculoskeletal disease, and many others.
This 2021 SDi report provides background and market data on 21 key technologies and supplies used by CGT providers, from the R&D phase through manufacturing and cryopreservation. The report offers market size, growth, segmentations, and vendor share.